
Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.
Daniel Carrizosa, MD, MS, is a physician at Atrium Health Levine Cancer Institute and associate professor of cancer medicine at Wake Forest University School of Medicine in Charlotte, North Carolina.

Experts outline AE risks—including ICANS, CRS, HLH—as T-cell engager use expands, highlighting the crucial role of nurses and APPs.

Published: August 10th 2025 | Updated: